Abbas Vafai

1.8k total citations
49 papers, 1.4k citations indexed

About

Abbas Vafai is a scholar working on Epidemiology, Genetics and Animal Science and Zoology. According to data from OpenAlex, Abbas Vafai has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 17 papers in Genetics and 14 papers in Animal Science and Zoology. Recurrent topics in Abbas Vafai's work include Herpesvirus Infections and Treatments (40 papers), Virus-based gene therapy research (16 papers) and Animal Virus Infections Studies (14 papers). Abbas Vafai is often cited by papers focused on Herpesvirus Infections and Treatments (40 papers), Virus-based gene therapy research (16 papers) and Animal Virus Infections Studies (14 papers). Abbas Vafai collaborates with scholars based in United States, Israel and Slovakia. Abbas Vafai's co-authors include Donald H. Gilden, Mary Wellish, Mary Devlin, Ravi Mahalingam, Vidya Shankar, Yechiel Becker, Y. Shtram, Zofia Wróblewska, Ronald S. Murray and Aud Nome Dueland and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Abbas Vafai

49 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abbas Vafai United States 19 1.2k 292 263 251 236 49 1.4k
Catherine Sadzot‐Delvaux Belgium 25 1.4k 1.2× 257 0.9× 323 1.2× 212 0.8× 260 1.1× 52 1.6k
W. A. Blyth United Kingdom 25 1.9k 1.6× 124 0.4× 229 0.9× 386 1.5× 113 0.5× 63 2.3k
A. A. Gershon United States 16 995 0.9× 210 0.7× 224 0.9× 158 0.6× 204 0.9× 19 1.1k
Vicki Traina‐Dorge United States 20 683 0.6× 128 0.4× 348 1.3× 142 0.6× 178 0.8× 53 1.3k
Charles Wohlenberg United States 16 850 0.7× 89 0.3× 228 0.9× 277 1.1× 44 0.2× 22 1.2k
Leigh Zerboni United States 34 2.4k 2.1× 513 1.8× 669 2.5× 449 1.8× 501 2.1× 52 2.7k
Susan M. Slanina United States 29 1.8k 1.6× 215 0.7× 366 1.4× 410 1.6× 77 0.3× 35 2.1k
C. Shimeld United Kingdom 22 1.1k 1.0× 67 0.2× 105 0.4× 150 0.6× 86 0.4× 36 1.5k
Jeffery L. Meier United States 26 1.3k 1.1× 101 0.3× 248 0.9× 229 0.9× 305 1.3× 55 1.7k
N Frenkeĺ United States 31 3.2k 2.8× 180 0.6× 291 1.1× 901 3.6× 134 0.6× 41 3.7k

Countries citing papers authored by Abbas Vafai

Since Specialization
Citations

This map shows the geographic impact of Abbas Vafai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbas Vafai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbas Vafai more than expected).

Fields of papers citing papers by Abbas Vafai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abbas Vafai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbas Vafai. The network helps show where Abbas Vafai may publish in the future.

Co-authorship network of co-authors of Abbas Vafai

This figure shows the co-authorship network connecting the top 25 collaborators of Abbas Vafai. A scholar is included among the top collaborators of Abbas Vafai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abbas Vafai. Abbas Vafai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tang, Xiaoling, Ju He, James Partin, & Abbas Vafai. (2010). COMPARATIVE ANALYSIS OF DIRECT FLUORESCENCE, ZENON LABELING, AND QUANTUM DOT NANOCRYSTAL TECHNOLOGY IN IMMUNOFLUORESCENCE STAINING. Journal of Immunoassay and Immunochemistry. 31(3). 250–257. 7 indexed citations
3.
Tang, Xiaoling, et al.. (2009). Stability of Varicella-Zoster Virus and Herpes Simplex Virus IgG Monoclonal Antibodies. Journal of Immunoassay and Immunochemistry. 30(2). 180–185. 8 indexed citations
4.
Liu, Hsi, et al.. (2008). Rapid identification and authentication of closely related animal cell culture by polymerase chain reaction. In Vitro Cellular & Developmental Biology - Animal. 44(7). 224–227. 8 indexed citations
5.
Tatti, Kathleen M., Patricia W. Greer, Elizabeth White, et al.. (2006). Morphologic, Immunologic, and Molecular Methods to Detect Bacillus anthracis in Formalin-Fixed Tissues. Applied immunohistochemistry & molecular morphology. 14(2). 234–243. 9 indexed citations
6.
Lin, Seh‐Ching, et al.. (2003). IDENTIFICATION AND AUTHENTICATION OF ANIMAL CELL CULTURE BY POLYMERASE CHAIN REACTION AMPLIFICATION AND DNA SEQUENCING. In Vitro Cellular & Developmental Biology - Animal. 39(10). 424–424. 18 indexed citations
7.
Shankar, Vidya, et al.. (2002). Therapeutic Applications of Monoclonal Antibodies. The American Journal of the Medical Sciences. 324(1). 14–30. 120 indexed citations
8.
Vafai, Abbas, et al.. (2000). Stability of a varicella-zoster virus glycoprotein E epitope. Archives of Virology. 145(1). 85–97. 9 indexed citations
9.
Vafai, Abbas. (1995). Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine. Vaccine. 13(14). 1336–1338. 25 indexed citations
10.
Vafai, Abbas. (1993). Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine. Vaccine. 11(9). 937–940. 18 indexed citations
11.
Asher, Yael, et al.. (1991). In vitro transcription and translation of proteins encoded by theBamHI-B genomic fragment of herpes simplex virus-1. Virus Genes. 5(2). 133–146. 5 indexed citations
12.
Mahalingam, Ravi, Gary F. Cabirac, Mary Wellish, Donald H. Gilden, & Abbas Vafai. (1990). In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase. Virus Genes. 4(2). 105–120. 5 indexed citations
13.
Mahalingam, Ravi, Mary Wellish, William Wolf, et al.. (1990). Latent Varicella–Zoster Viral DNA in Human Trigeminal and Thoracic Ganglia. New England Journal of Medicine. 323(10). 627–631. 199 indexed citations
15.
Forghani, Bagher, et al.. (1990). Monoclonal antibody to immediate early protein encoded by varicella-zoster virus gene 62. Virus Research. 16(2). 195–210. 36 indexed citations
16.
Vafai, Abbas, et al.. (1989). Existence of similar antigenic-sites on varicella-zoster virus gpI and gpIV. Virus Research. 13(4). 319–336. 14 indexed citations
17.
Mahalingam, Ravi, Mary Wellish, Gary F. Cabirac, Donald H. Gilden, & Abbas Vafai. (1988). Regulation of varicella zoster virus gene 27 translation in vitro by upstream sequences. Virus Research. 10(2-3). 193–204. 1 indexed citations
18.
Vafai, Abbas, Ravi Mahalingam, Gary O. Zerbe, Mary Wellish, & Donald H. Gilden. (1988). Detection of Antibodies to Varicella-Zoster Virus Proteins in Sera from the Elderly. Gerontology. 34(5-6). 242–249. 23 indexed citations
19.
Vafai, Abbas, et al.. (1984). Analysis of three late varicella-zoster virus proteins, a 125,000-molecular-weight protein and gp1 and gp3. Journal of Virology. 52(3). 953–959. 36 indexed citations
20.
Vafai, Abbas, et al.. (1982). A novel cell transformation with DNA-containing cytoplasmic yaba tumor poxvirus. Virology. 120(1). 77–92. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026